DeutschNewstral
Article
jdsupra.com on 2020-10-05 20:39
OIG Issues Advisory Opinion for Pharmaceutical Manufacturer’s Cost-Sharing Assistance Proposal
Related news
- OIG Issues Advisory Opinion Giving the Green Light to a Pharmaceutical Manufacturer’s Plan to Provide Limited Functionality Smartphones to Financially Needy Patients for Adherence Data Monitoringjdsupra.com
- OIG Advisory Opinion Rejects Pharmaceutical Manufacturer’s Proposed Beneficiary Cost-Sharing Programjdsupra.com
- OIG Allows Pharmaceutical Manufacturer to Provide Financial Assistance for Travel, Lodging and Other Expenses to Certain Patients Prescribed the Manufacturer's Drug in Advisory Opinion 20-09jdsupra.com
- OIG Nixes Pharmaceutical Cost-Sharing Subsidy Program Under AKSjdsupra.com
- OIG Permits Medical Device Manufacturer’s Cost-Sharing Subsidies for Medicare Beneficiaries in Clinical Trialjdsupra.com
- OIG Permits Pharmaceutical Manufacturer to Offer Free Drug to Patients in Advisory Opinion 21-01jdsupra.com
- OIG Greenlights Manufacturer’s Limited Free Drug Programjdsupra.com
- OIG Tightens Requirements of Prior Favorable Advisory Opinion on Charity Patient Assistance Program for Cancer Drugsjdsupra.com
- OIG Issues Advisory Opinion Allowing Pharmaceutical Company’s Payment of Travel, Food and Lodging Expenses for Indigent and Rural Patientsjdsupra.com
- OIG Issues Advisory Opinion Regarding Pharmaceutical Companies’ Proposed Arrangement to Provide Cost-Sharing Subsidiesjdsupra.com
- OIG Issues Advisory Opinion Permitting Cost-Sharing for Medicare-Reimbursable Items and Services in a Clinical Trialjdsupra.com
- OIG Issues Four Advisory Opinionsjdsupra.com
- OIG Advisory Opinion Permits a Pharmaceutical Manufacturer to Provide Financial Assistance to Needy Patients Receiving Risky Cell Therapyjdsupra.com
- Summary and Key Considerations of Recent HHS-OIG Advisory Opinion on Pharmaceutical Patient Assistance Program for Rare Disordersjdsupra.com
- OIG Issues Favorable Advisory Opinion Regarding Pharmaceutical Manufacturer Arrangement to Provide Financial Assistance to Potentially Eligible Patientsjdsupra.com
- OIG Approves Charitable Organization's Patient Assistance Programjdsupra.com
- OIG Issues Favorable Advisory Opinion Regarding the Subsidization of Certain Medicare Cost-Sharing Obligations in the Context of a Clinical Trialjdsupra.com
- OIG Approves Pharmaceutical Manufacturer’s Loaning of Smartphones to Support Digital Medicine (DM)jdsupra.com
- OIG Issues Favorable Opinion for Pharmaceutical Manufacturer's Free Drug Programjdsupra.com
- HHS-OIG: Pharma Manufacturer’s Proposed Copayment Assistance Program ‘Highly Suspect’ Under Federal Anti-Kickback Statutejdsupra.com